Net income from continuing operations attributable to NovaMed in the third quarter of 2009 increased 4 percent to $1.862 million from $1.798 million in the prior year third quarter. Net cash provided by operations increased 15 percent to $7.133 million in the third quarter of 2009 from $6.196 million in the prior year third quarter. EBITDA increased 9 percent to $7.217 million. Same-facility revenue declined 1 percent in the third quarter of 2009.
For the nine months ending Sept. 30, total net revenue grew to $116.634 million, up 11 percent from $105.043 million for the first nine months last year, despite a 2 percent decline in same-facility net revenue. Net income from continuing operations attributable to NovaMed increased 10 percent to $5.713 million in the first nine months of 2009 compared to $5.177 million in the first nine months of 2008. Net cash provided by operations increased 13 percent to $19.225 million o in the first nine months of 2009 from $16.998 million in the first nine months of 2008.
Read the release on NovaMed’s third-quarter earnings.
